Fact Sheet: sGnRHa INAD 11-375

for detailed information, see INAD study protocol use links on the left
last updated: 1 December 2011

The following links are specific to:
sGnRHa

Drug summary & history

List of FDA-Approved drugs

Drug forms to be completed

Examples of completed forms

INAD study protocol

Material Safety Data Sheet
(MSDS)

Study Summaries

Print this drug fact sheet

Print all drug fact sheets

Sign-up via the INAD Program Management System (IPMS)

Information on EPA's National Pollutant Discharge Elimination System (NPDES) Permits

Authorization & Categorical Exclusion Letters

Objective/purpose: Collect supportive and pivotal data needed to establish the effectiveness of sGnRHa/Ovaplant® to induce gamete maturation in a variety of fish species.
Drug name: Ovaplant®; Salmon Gonadotropin - Releasing Hormone analogue
[Des-Gly10, D-Arg6, Trp7, Leu8] - LHRH, ethyl amide)
Source of drug: Western Chemical, Inc.
Address: 1269 Lattimore Road
Ferndale, WA 98248 USA
Contact: Attention: Jim Brackett
Toll Free: 800-283-5292
Tel: 360-384-5898
email: brackett@wchemical.com
webpage: http://www.syndel.com/
Target pathogen(s): Not Applicable
Method of administration: Pellet-implant treatment
Treatment dosage: 10 - 75 micrograms sGnRHa per kilogram body weight
Treatment regimen: Implant: Single treatment
Withdrawal period: Implant: No Release. All treated broodfish must be maintained indefinitely or destroyed.
Required test parameters: Investigator must collect data reporting percent ovulation and/or percent spermiation in treated fish. Investigator should also report general fish behavior and any adverse effects relating to treatment.
Limitations or restrictions on use: Investigator must follow all instructions in the Study Protocol for INAD 11-375 regarding drug acquisition and handling, fish treatment and disposition, and data reporting requirements.

Drug discharge must be in compliance with local NPDES permitting requirements.
Required INAD fee: $400.00 per facility per year
AADAP contact for other information: Ms. Bonnie Johnson, FWS - AADAP
Phone: 406-994-9905
Fax: 406-582-0242

bonnie_johnson@fws.gov
Disclaimer: Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government.